How I’d invest £10k to create a passive income for life

Rupert Hargreaves explains the strategy he would use to generate a passive income for life with just £10,000 right now.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

pensive bearded business man sitting on chair looking out of the window

Image source: Getty Images

I firmly believe that investing in stocks and shares is one of the easiest ways to generate a passive income for life. I also think it is possible to start building a passive income stream with an investment of just £10,000.

With that in mind, here is the strategy I would use to invest a lump sum in equities today with the goal of generating income for life.

Generating a passive income

Buying equities for dividend income is a very straightforward way to generate a passive income stream. However, the strategy does come with some downsides.

Dividend income is paid out of profits. Therefore, if a company’s profitability suddenly declines, it may not be able to pay out as much income to shareholders as in previous years. Therefore, investors need to be prepared for a sudden dividend cut if an operating environment changes significantly.

I will be keeping an eye on this when it comes to all of the companies outlined below. These corporations might look like attractive dividend investments, but their prospects could change suddenly if the operating environment deteriorates.

Even after taking these risks into account, I am still convinced that equities are one of the best passive income assets to own.

Rather than focusing on the highest yielding stocks on the market, I would buy a mix of higher and lower yielding equities from my portfolio.

I think this could open the door to more capital growth as companies that are not paying out all of their profits to investors tend to invest more in their respective businesses.

This can lead to faster earnings growth rates in the long run.

Growth stocks 

This is why I would acquire pharmaceutical companies AstraZeneca and Hikma for my portfolio today. The latter yields just under 2%, while the former yields around 2.5%.

These are not the highest yields on the market. Still, both organisations are also investing significantly in developing their drugs pipelines. I think this should help underpin earnings growth and potentially dividend growth in the years ahead.

Both companies may have to overcome challenges, including competitive forces and regulatory factors, which could weigh on growth.

At the other end of the dividend spectrum, I would also look to acquire Direct Line and home builder Persimmon for my passive income portfolio. The former supports a dividend yield of around 8%, while the latter yields around 9%.

Cash returns 

These companies have a fantastic track record of returning lots of cash to investors. Their near double-digit dividend yields stand testament to these qualities. They also have strong balance sheets, which are stuffed full of cash. This should help support their dividend policies in the years ahead.

Still, their dividend credentials are far from guaranteed. A sudden drop in profitability could hit either outfit at a moment’s notice. In this scenario, they would have to reconsider their payouts.

That is why I would combine both lower-yielding and higher-yielding stocks in my passive income portfolio.

Buying the four companies outlined above would yield around 4% on my £10,000 lump sum. That could generate a passive income of about £400 a year for life.

I could then build this income stream by steadily depositing more into my investment account and acquiring a higher number of shares in the firm’s outlined above.

Rupert Hargreaves owns Direct Line Insurance. The Motley Fool UK has recommended Hikma Pharmaceuticals. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Person holding magnifying glass over important document, reading the small print
Investing Articles

Aviva’s share price is down 13% to under £7, despite outstanding 2025 results! Time for me to buy more?

I think Aviva’s share price reflects an outdated view of the business, and that gap between perception and reality is…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

Shell’s £33+ share price is near an all-time high, so why am I going to buy more as soon as possible?

Shell's strong cash generation and improving growth drivers contrast with a share price well below my valuation, suggesting major long‑term…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

An 8.4% forecast yield but down 16%! Time for me to buy more of this FTSE 100 passive income star?

This FTSE 100 passive‑income machine is delivering rising payouts and strong forecasts, and its share price suggests the market hasn’t…

Read more »

CEO Mark Zuckerberg at F8 2019 event
Investing Articles

£10,000 invested in Meta Platforms Stock 5 years ago is now worth…

Meta Platforms has been throwing good money after bad at Reality Labs since 2021, but the stock has more than…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

£7,500 invested in Diageo shares 5 weeks ago is now worth…

Our writer wonders if Diageo shares are worth a look at a 14-year low, or whether this FTSE 100 spirits…

Read more »

National Grid engineers at a substation
Investing Articles

Is Warren Buffett’s firm about to buy this FTSE 100 company?

There’s always speculation about what Warren Buffett’s company might be doing. But one UK idea has a bit more to…

Read more »

Female student sitting at the steps and using laptop
Growth Shares

Down 17% in a month, this household FTSE 250 stock looks cheap

Jon Smith acknowledges the recent market sell-off but points out a FTSE 250 stock that he believes offers a long-term…

Read more »

Hydrogen testing at DLR Cologne
Investing Articles

Rolls-Royce’s share price has plunged 16% from its highs! Time to buy?

Rolls-Royce's share price has tumbled in less than three weeks. Royston Wild asks: is the FTSE 100 engineering stock now…

Read more »